These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23066888)

  • 1. Chemical structure determines target organ carcinogenesis in rats.
    Carrasquer CA; Malik N; States G; Qamar S; Cunningham SL; Cunningham AR
    SAR QSAR Environ Res; 2012 Oct; 23(7-8):775-95. PubMed ID: 23066888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship analysis of rat mammary carcinogens.
    Cunningham AR; Moss ST; Iype SA; Qian G; Qamar S; Cunningham SL
    Chem Res Toxicol; 2008 Oct; 21(10):1970-82. PubMed ID: 18759503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures.
    Ashby J; Paton D
    Mutat Res; 1993 Mar; 286(1):3-74. PubMed ID: 7678908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary carcinogen-protein binding potentials: novel and biologically relevant structure-activity relationship model descriptors.
    Cunningham AR; Qamar S; Carrasquer CA; Holt PA; Maguire JM; Cunningham SL; Trent JO
    SAR QSAR Environ Res; 2010 Jul; 21(5-6):463-79. PubMed ID: 20818582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship models for rat carcinogenesis and assessing the role mutagens play in model predictivity.
    Carrasquer CA; Batey K; Qamar S; Cunningham AR; Cunningham SL
    SAR QSAR Environ Res; 2014; 25(6):489-506. PubMed ID: 24697549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive and carcinogen-derived DNA binding as a basis for the assessment of potency of chemical carcinogens.
    Lutz WK
    Adv Exp Med Biol; 1981; 136 Pt B():1349-65. PubMed ID: 7344514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global structure-activity relationship model for nonmutagenic carcinogens using virtual ligand-protein interactions as model descriptors.
    Cunningham AR; Carrasquer CA; Qamar S; Maguire JM; Cunningham SL; Trent JO
    Carcinogenesis; 2012 Oct; 33(10):1940-5. PubMed ID: 22678118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of structural features and associated mechanisms of action for carcinogens in rats.
    Cunningham AR; Klopman G; Rosenkranz HS
    Mutat Res; 1998 Aug; 405(1):9-27. PubMed ID: 9729240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mode of action of organic carcinogens on cellular structures.
    Luch A
    EXS; 2006; (96):65-95. PubMed ID: 16383015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 'genotoxic' and 'non-genotoxic' alerts for cancer in mice: the carcinogenic potency database.
    Cunningham AR; Rosenkranz HS; Zhang YP; Klopman G
    Mutat Res; 1998 Feb; 398(1-2):1-17. PubMed ID: 9626960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours.
    Bignold LP
    Carcinogenesis; 2004 Mar; 25(3):299-307. PubMed ID: 14604890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of genotoxic carcinogens and non-genotoxic carcinogens.
    Hayashi Y
    Exp Toxicol Pathol; 1992 Dec; 44(8):465-71. PubMed ID: 1493365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic events during the process of cell transformation induced by carcinogens (review).
    Nguyen-Ba G; Vasseur P
    Oncol Rep; 1999; 6(4):925-32. PubMed ID: 10373683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between bioassay dose-level, mutagenicity to Salmonella, chemical structure and sites of carcinogenesis among 226 chemicals evaluated for carcinogenicity by the U.S. NTP.
    Brown LP; Ashby J
    Mutat Res; 1990 May; 244(1):67-76. PubMed ID: 2336072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage and repair in mutagenesis and carcinogenesis: implications of structure-activity relationships for cross-species extrapolation.
    Vogel EW; Nivard MJ; Ballering LA; Bartsch H; Barbin A; Nair J; Comendador MA; Sierra LM; Aguirrezabalaga I; Tosal L; Ehrenberg L; Fuchs RP; Janel-Bintz R; Maenhaut-Michel G; Montesano R; Hall J; Kang H; Miele M; Thomale J; Bender K; Engelbergs J; Rajewsky MF
    Mutat Res; 1996 Jun; 353(1-2):177-218. PubMed ID: 8692191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogen binding to DNA.
    Straub KM; Burlingame AL
    Biomed Mass Spectrom; 1981 Sep; 8(9):431-5. PubMed ID: 7306680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP.
    Ashby J; Tennant RW
    Mutat Res; 1988 Jan; 204(1):17-115. PubMed ID: 3277047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.